Borremiddleton9007

Our understanding of the neurofunctional mechanisms of speech production and their pathologies is still incomplete. In this paper, a comprehensive model of speech production based on the Neural Engineering Framework (NEF) is presented. This model is able to activate sensorimotor plans based on cognitive-functional processes (i.e., generation of the intention of an utterance, selection of words and syntactic frames, generation of the phonological form and motor plan; feedforward mechanism). Since the generation of different states of the utterance are tied to different levels in the speech production hierarchy, it is shown that different forms of speech errors as well as speech disorders can arise at different levels in the production hierarchy or are linked to different levels and different modules in the speech production model. In addition, the influence of the inner feedback mechanisms on normal as well as on disordered speech is examined in terms of the model. The model uses a small number of core concepts provided by the NEF, and we show that these are sufficient to create this neurobiologically detailed model of the complex process of speech production in a manner that is, we believe, clear, efficient, and understandable.Numerous studies find that creativity is not only associated with low effort and flexible processes but also associated with high effort and persistent processes especially when defensive behavior is induced by negative emotions. The important role of self-esteem is to buffer negative emotions, and individuals with low self-esteem are prone to instigating various forms of defensive behaviors. check details Thus, we thought that the relationships between trait creativity and executive control brain networks might be modulated by self-esteem. The resting-state electroencephalogram (RS-EEG) microstates can be divided into four classical types (MS1, MS2, MS3, and MS4), which can reflect the brain networks as well as their dynamic characteristic. Thus, the Williams Creative Tendency Scale (WCTS) and Rosenberg Self-esteem Scale (RSES) were used to investigate the modulating role of self-esteem on the relationships between trait creativity and the RS-EEG microstates. As our results showed, self-esteem consistently modulated the relationships between creativity and the duration and contribution of MS2 related to visual or imagery processing, the occurrence of MS3 related to cingulo-opercular networks, and transitions between MS2 and MS4, which were related to frontoparietal control networks. Based on these results, we thought that trait creativity was related to the executive control of bottom-up processing for individuals with low self-esteem, while the bottom-up information from vision or visual imagery might be related to trait creativity for individuals with high self-esteem.Detecting changes in the environment is fundamental for our survival. According to predictive coding theory, detecting these irregularities relies both on incoming sensory information and our top-down prior expectations (or internal generative models) about the world. Prediction errors (PEs), detectable in event-related potentials (ERPs), occur when there is a mismatch between the sensory input and our internal model (i.e., a surprise event). Many changes occurring in our environment are irrelevant for survival and may remain unseen. Such changes, even if subtle, can nevertheless be detected by the brain without emerging into consciousness. What remains unclear is how these changes are processed in the brain at the network level. Here, we used a visual oddball paradigm in which participants engaged in a central letter task during electroencephalographic (EEG) recordings while presented with task-irrelevant high- or low-coherence background, random-dot motion. Critically, once in a while, the direction of the dots changed. After the EEG session, we confirmed that changes in motion direction at high- and low-coherence were visible and invisible, respectively, using psychophysical measurements. ERP analyses revealed that changes in motion direction elicited PE regardless of the visibility, but with distinct spatiotemporal patterns. To understand these responses, we applied dynamic causal modeling (DCM) to the EEG data. Bayesian Model Averaging showed visible PE relied on a release from adaptation (repetition suppression) within bilateral MT+, whereas invisible PE relied on adaptation at bilateral V1 (and left MT+). Furthermore, while feedforward upregulation was present for invisible PE, the visible change PE also included downregulation of feedback between right MT+ to V1. Our findings reveal a complex interplay of modulation in the generative network models underlying visible and invisible motion changes.Olfaction plays an important role in the evaluation, motivation, and palatability of food. The chemical identity of odorants is coded by a spatial combination of activated glomeruli in the olfactory bulb, which is referred to as the odor map. However, the functional roles of the olfactory cortex, a collective region that receives axonal projections from the olfactory bulb, and higher olfactory centers in odor-guided eating behaviors are yet to be elucidated. The olfactory tubercle (OT) is a component of the ventral striatum and forms a node within the mesolimbic dopaminergic pathway. Recent studies have revealed the anatomical domain structures of the OT and their functions in distinct odor-guided motivated behaviors. Another component of the ventral striatum, the nucleus accumbens, is well known for its involvement in motivation and hedonic responses for foods, which raises the possibility of functional similarities between the OT and nucleus accumbens in eating. This review first summarizes recent findings on the domain- and neuronal subtype-specific roles of the OT in odor-guided motivated behaviors and then proposes a model for the regulation of eating behaviors by the OT.Neurons have been long regarded as the basic functional cells of the brain, whereas astrocytes and microglia have been regarded only as elements of support. However, proper intercommunication among neurons-astrocytes-microglia is of fundamental importance for the functional organization of the brain. Perturbation in the regulation of brain energy metabolism not only in neurons but also in astrocytes and microglia may be one of the pathophysiological mechanisms of neurodegeneration, especially in hypoxia/ischemia. Glial activation has long been considered detrimental for survival of neurons, but recently it appears that glial responses to an insult are not equal but vary in different brain areas. In this review, we first take into consideration the modifications of the vascular unit of the glymphatic system and glial metabolism in hypoxic conditions. Using the method of triple-labeling fluorescent immunohistochemistry coupled with confocal microscopy (TIC), we recently studied the interplay among neurons, astrus and interconnected hippocampal areas, demonstrate that glial response to the same hypoxic insult is not equal but varies significantly. Understanding the differences of glial reactivity is of great interest to explain the differential susceptibility of hippocampal areas to hypoxia/ischemia. Further studies may evidence the differential reactivity of glia in different brain areas, explaining the higher or lower sensitivity of these areas to different insults and whether glia may represent a target for future therapeutic interventions.Maternal exposure to the valproate short-chain fatty acid (SCFA) during pregnancy is known to possibly induce autism spectrum disorders (ASDs) in the offspring. By contrast, case studies have evidenced positive outcomes of this anticonvulsant drug in children with severe autism. Interestingly, the same paradoxical pattern applies to the IL-17a inflammatory cytokine involved in the immune system regulation. Such joint apparent contradictions can be overcome by pointing out that, among their respective signaling pathways, valproate and IL-17a share an enhancement of the "type A monoamine oxidase" (MAOA) enzyme carried by the X chromosome. In the Guided Propagation (GP) model of autism, such enzymatic rise triggers a prenatal epigenetic downregulation, which, without possible X-inactivation, and when coinciding with genetic expression variants of other brain enzymes, results in the delayed onset of autistic symptoms. The underlying imbalance of synaptic monoamines, serotonin in the first place, would reflect a mismatch between the environment to which the brain metabolism was prepared during gestation and the postnatal actual surroundings. Following a prenatal exposure to molecules that significantly elicit the MAOA gene expression, a daily treatment with the same metabolic impact would tend to recreate the fetal environment and contribute to rebalance monoamines, thus allowing proper neural circuits to gradually develop, provided behavioral re-education. Given the multifaceted other players than MAOA that are involved in the regulation of serotonin levels, potential compensatory effects are surveyed, which may underlie the autism heterogeneity. This explanatory framework opens up prospects regarding autism prevention and treatment, strikingly in line with current advances along the gut microbiome-brain axis.Selective negative allosteric modulators (NAMs), targeting α5 subunit-containing GABAA receptors (GABAARs) as potential therapeutic targets for disorders associated with cognitive deficits, including Alzheimer's disease (AD), continually fail clinical trials. We investigated whether this was due to the change in the expression of α5 GABAARs, consequently altering synaptic function during AD pathogenesis. Using medicinal chemistry and computational modeling, we developed aqueous soluble hybrids of 6,6-dimethyl-3-(2-hydroxyethyl) thio-1-(thiazol-2-yl)-6,7-dihydro-2-benzothiophene-4(5H)-one, that demonstrated selective binding and high negative allosteric modulation, specifically for the α5 GABAAR subtypes in constructed HEK293 stable cell-lines. Using a knock-in mouse model of AD (APPNL-F/NL-F), which expresses a mutant form of human amyloid-β (Aβ), we performed immunofluorescence studies combined with electrophysiological whole-cell recordings to investigate the effects of our key molecule, α5-SOP002 in the hippocampal CA1 region. In aged APPNL-F/NL-F mice, selective preservation of α5 GABAARs was observed in, calretinin- (CR), cholecystokinin- (CCK), somatostatin- (SST) expressing interneurons, and pyramidal cells. Previously, we reported that CR dis-inhibitory interneurons, specialized in regulating other interneurons displayed abnormally high levels of synaptic inhibition in the APPNL-F/NL-F mouse model, here we show that this excessive inhibition was "normalized" to control values with bath-applied α5-SOP002 (1 μM). However, α5-SOP002, further impaired inhibition onto CCK and pyramidal cells that were already largely compromised by exhibiting a deficit of inhibition in the AD model. In summary, using a multi-disciplinary approach, we show that exposure to α5 GABAAR NAMs may further compromise aberrant synapses in AD. We, therefore, suggest that the α5 GABAAR is not a suitable therapeutic target for the treatment of AD or other cognitive deficits due to the widespread neuronal-networks that use α5 GABAARs.